You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease

Article metrics

Article menu

Download PDFPDF

XML
Hypothesis
Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease

 

Online download statistics by month:

Online download statistics by month: February 2020 to November 2024

AbstractFullPdf
Feb 2020353353105
Mar 202023723770
Apr 202014014034
May 2020717116
Jun 202036366
Jul 2020272722
Aug 2020293019
Sep 2020535318
Oct 2020505031
Nov 202040409
Dec 2020686825
Jan 2021616121
Feb 2021505019
Mar 2021565619
Apr 2021333311
May 2021575729
Jun 2021424219
Jul 2021484822
Aug 202146468
Sep 2021515119
Oct 2021484826
Nov 2021494927
Dec 2021323214
Jan 2022404418
Feb 2022182013
Mar 2022535823
Apr 2022678336
May 2022465117
Jun 2022555915
Jul 2022545820
Aug 2022444722
Sep 2022505017
Oct 2022424212
Nov 2022353724
Dec 202246476
Jan 2023636617
Feb 2023636420
Mar 2023616313
Apr 2023405015
May 2023414119
Jun 202332336
Jul 2023383814
Aug 2023505014
Sep 2023454513
Oct 20231001017
Nov 20233383406
Dec 2023808513
Jan 2024333417
Feb 2024383813
Mar 2024484871
Apr 2024555516
May 2024424216
Jun 2024596012
Jul 2024727318
Aug 2024514914
Sep 2024393912
Oct 2024444421
Nov 2024535417
Total371237861196